期刊文献+

Establishment and evaluation of Type 2 Diabetes Mellitus andits complications induced by low dose of multiple streptozotocin

下载PDF
导出
摘要 Objective: To explore a simple, economical and feasible method for establishing type 2 diabetes mellitus and its complication model. Method: SD rats were randomly divided into two groups: normal group (15 rats) normal diet, model group (20 rats) with high glucose and high fat diet. After 2 weeks of feeding, model group was injected low dose(30mg/Kg) streptozotocin in the abdominal cavity, once a day for 6 days, normal group was injected with the same dose of citric acid buffer. Observe the changes of rat diet, body, hair, spirit, urine volume, and monitor weight, blood glucose. After 6 weeks, fast insulin, blood lipid, serum calcium, phosphorus and other biochemical indexes of rats, after HE staining observe morphologic variations changes of pancreas and kidney using microscope, and the changes of femoral bone in SD rats. Results: Compared with the normal group, the model group showed obvious symptoms, drink more, eat more, polyuria, emaciation, hyperglycemia, low calcium, low phosphorus, hyperlipidemia and other metabolic abnormalities, pancreatic atrophy, tissue fibrosis, glomerular area increased, basement membrane thickening, osteoporosis. Conclusion:High glucose and high fat diet combined with repeated intraperitoneal injecti on of low dose STZ can be successfully established the model of type 2 diabetes, and its high successful rate, low mortality rate, relatively simple, economical and feasible, has a certain significance of research on diabetes and its complications.
出处 《Journal of Hainan Medical University》 2020年第11期18-22,共5页 海南医学院学报(英文版)
基金 Wuhan municipal health and family planning research fund (WZ14A02)
  • 相关文献

参考文献2

二级参考文献32

  • 1姚迪,杜红伟,秦新梅,胡克恒,梁秀华.微量元素对链脲佐菌素所致大鼠胰岛β细胞损害预防作用的实验研究[J].白求恩医科大学学报,1995,21(1):4-7. 被引量:14
  • 2谢明智 刘海帆 等.实验性肥胖及糖尿病大鼠模型[J].药学学报,1985,20(11):801-801.
  • 3White FR. Steptozotocin. Cancer Chemother Rep, 1963,30 : 49-53.
  • 4Herr RR, Eble TE, Bergy ME, et al. Isolation and characterization of streptozotocin. Antibiot Annu, 1959-1960,7 : 236 -240.
  • 5Rakieten N, Rakieten ML, Nadkarni MR. Studies on the diabetogenic action of streptozotocin ( NSC-37917 ) . Cancer Chemother Rep, 1963,29:91-98.
  • 6Dulin WE, Soret MG. Chemically and hormonally induced diabetes In:Volk B, Wellman K. (Eds) : The diabetic pancreas. Plenum Press, New York, 1977:425-465.
  • 7Hosokawa M, Dolci W, Thorens B. Differential Sensitivity of GLUT1^- and GLUT2^- expressing beta ceils to streptozotocin. Biochem Biophysic Res Commun,2001,289 (5) : 1114- 1117.
  • 8Heimberg H, De Vos A, Pipeleers D, et al. Differences in glucose transporter gene expression between rat pancreatic alpha- and beta-cells are correlated to differences in glucose transport but not in glucose utilization. J Biol Chem, 1995, 270(15) :8971-8975.
  • 9De Vos A, Heimberg H, Quartier E, et al. Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J Clin Invest, 1995,96 (5) : 2489-2495.
  • 10Tuch BE, Turtle JR, Simeonovic CJ. Streptozotocin is not toxic to the human fetal B cell. Diabetologia, 1989,32 (9) : 678-684.

共引文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部